JAGX - Jaguar Animal Health Inc logo

Jaguar Animal Health Inc

JAGX
Rev 196xtop 1%10Y
Compare JAGX Hold

Jaguar Health, Inc. develops plant-based prescription medications for gastrointestinal issues in humans and animals. Its products include Mytesi for non-infectious diarrhea in adults and Canalevia-CA1 for chemotherapy-induced diarrhea in dogs.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth31.38%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth141.26%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.5
Net Growth30.28%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth6x
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-148.86%
Net Trend50%
Net Income Consistency
Rev Growth196x
Rev Trend70%
Revenue Consistency
All Time
Score
Net Growth-125.07%
Net Trend55%
Net Income Consistency
Rev Growth107x
Rev Trend64%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Jaguar Animal Health Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. JAGX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 2.15โ€”
1 Year2025-10-22
$ 992.25-99.78%
5 Years2021-10-22
$ 1000K-100.00%
10 Years2016-10-21
$ 1000K-100.00%
All Time2015-05-13
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 27M-$ 36M$ 3M
2025$ 11M-$ 53M$ 968K
2024$ 11M-$ 38M$ 8M
2023$ 9M-$ 41M$ 6M
2022$ 11M-$ 47M$ 5M
2021$ 4M-$ 52M$ 17M
2020$ 9M-$ 33M$ 8M
2019$ 5M-$ 38M$ 3M
2018$ 4M-$ 32M$ 2M
2017$ 4M-$ 21M$ 520.7K
2016$ 141.52K-$ 14M$ 950.98K
IPO2015$ 258.38K-$ 16M$ 7M
JAGX - Jaguar Animal Health Inc logo

Jaguar Animal Health Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 9M to $ 11M and net income went from -$ 33M to -$ 53M. Revenue increased in 3 of those 5 years; net income in 4.

Across Jaguar Animal Health Inc's full reported history, from 2015 to 2025, revenue grew from $ 258.38K to $ 11M and net income went from -$ 16M to -$ 53M. Revenue increased in 64% of the years measured; net income in 55%.

Jaguar Animal Health Inc currently holds a 5-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.

Membership

Explore JAGX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies